Longeveron LLC
Price & Volume
Stats
See more52W Range | $0.59-$2.24 |
Market Cap | $14.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $1.4M |
Revenue Growth (YoY) | -82.3% |
Gross Profit (12 Mos) | $1M |
Diluted EPS | -$0.98 |
News
See moreYahoo Finance • yesterday
MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26
Yahoo Finance • 10 days ago
Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
Yahoo Finance • 17 days ago
Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy
Yahoo Finance • last month
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
About
CEO | Mr. Than Powell |
CFO | Ms. Lisa A. Locklear M.B.A. |
Address | Life Science & Technology Park, Miami, FL, United States, 33136 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
